Vijay Jayaprakash

Vijay Jayaprakash currently serves as the Senior Vice President of Clinical Development at Mural Oncology, managing Clinical Development, Clinical Pharmacology, Translational Medicine, and Patient Safety since July 2024. Prior to this role, Vijay held the position of Vice President of Clinical Development & Patient Safety at HUTCHMED, overseeing early asset portfolio development and leading programs for small molecule inhibitors in various cancers from November 2020 to July 2024. Vijay's extensive experience in clinical development includes significant roles at Bristol Myers Squibb, where leadership spanned multiple oncology programs, particularly in hematology, and at AstraZeneca, focusing on immuno-oncology registrational trials. Academic contributions include positions at Roswell Park Comprehensive Cancer Center and the University at Buffalo, with a strong background in cancer research and prevention. Educational credentials include degrees from the University at Buffalo, Tamil Nadu Dr. M.G.R. Medical University in Chennai, and the University of Washington.